ERBB2 and breast carcinoma: As seen in Figure 4, ADMC sensitized with anti-HER2/neu IgE induced significant (p < 0.05) mediator release through FcεRI when co-incubated with the HER2/neu-positive SK-BR-3 breast cancer cells.